Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
about
History of Nephrotic Syndrome and Evolution of its TreatmentRecent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in ChildrenTreatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two DecadesCyclic nucleotide signalling in kidney fibrosis.Repository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report.Focal segmental glomerulosclerosis: molecular genetics and targeted therapiesActhar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.Changing the Paradigm for the Treatment and Development of New Therapies for FSGS.MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy.Adrenocorticotropic hormone analog use for podocytopathiesThe podocyte as a direct target for treatment of glomerular disease?Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance.Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist.Acquired Resistance to Corticotropin Therapy in Nephrotic Syndrome: Role of De Novo Neutralizing Antibody.Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key IndicationsAvailable and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults.Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis.Focal Segmental Glomerulosclerosis.Steroid-resistant nephrotic syndrome: a persistent challenge for pediatric nephrology.What are we missing in the clinical trials of focal segmental glomerulosclerosis?Low-dose synthetic adrenocorticotropic hormone-analog therapy for nephrotic patients: results from a single-center pilot study.Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.A case report of adrenocorticotropic hormone to treat recurrent focal segmental glomerular sclerosis post-transplantation and biomarker monitoring.Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy.Investigational drugs in development for focal segmental glomerulosclerosis.Clinical trials in minimal change disease.
P2860
Q26745891-BA0AA251-066A-419D-A29E-FA83E84F0D7CQ26747770-F723D924-7BF3-4037-A7A7-B2D11E6FE438Q26752836-977417EA-9E37-4424-807B-56B5C5575BBCQ35138860-132EC981-1521-46B8-882E-D0C14A9265FBQ35219562-EF891B3B-5DF5-4C3C-A36B-FB8812C1CD3EQ35686453-C16069FB-8C01-4A06-B2F4-D9753C8E62CDQ35976834-AA94A929-5376-4927-8F36-FEB800FFEA7EQ36717656-6CF81D2A-F6D2-4EDB-81A4-B5067DB633DFQ36980645-0FAABF15-95FE-41C8-B0D9-612E7D3889B0Q37070458-603F95E4-E084-43F6-9D5F-17C746B4FD37Q37139449-E3EB1084-69A9-4C26-A389-BABB9ADF5110Q37651364-FE414241-FE07-4BA7-B2A1-D2A32E05472AQ38192853-716278D1-D45A-454D-AA6B-3CEFA5035631Q38667777-C3331179-884B-494E-8996-9AF2AADE5F0FQ38703169-53B39506-D4A9-420E-BA63-3ED43AFD91BBQ38805701-69FB7859-B1E8-45D2-8B54-80CBA6FFD372Q38858772-51B1BDB5-8B01-4497-9DBC-693CDE43D618Q38938623-38E57A90-0111-4390-96FF-7CF7593AE4D8Q38991259-22FBC924-B86F-4F3C-AE98-C5DEC6D687FEQ39229298-99553750-074D-4501-87DE-F222E09066F5Q41467613-0AA9557A-0ACC-4557-BB73-588B151C4DA7Q41688065-62226569-CEA4-47C2-97A5-1A65097FE41BQ43195589-04AF3B24-447E-4E0F-B2D3-40B30841F680Q47130208-6F5E12D6-23E6-4D0C-A370-64F631529AADQ51840896-1994F581-4CC4-432E-8A91-F60284339DD9Q53368686-23090415-A9AD-4102-9285-347AA9D9891C
P2860
Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
@en
Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
@nl
type
label
Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
@en
Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
@nl
prefLabel
Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
@en
Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
@nl
P2093
P2860
P356
P1476
Treatment of idiopathic FSGS with adrenocorticotropic hormone gel
@en
P2093
Andrew S Bomback
Gerald B Appel
Jai Radhakrishnan
Jonathan Hogan
Kshama Mehta
Maya K Rao
Richard A Lafayette
P2860
P304
P356
10.2215/CJN.02840313
P577
2013-09-05T00:00:00Z